Eurofins Scientific (ERF.PA) Stock Price

Eurofins Scientific Price

🇱🇺Frankfurt·CLOSED
67.04EUR
Market closed
Today +/-
Today %

Eurofins Scientific (ERF.PA) Stock | ISIN FR0014000MR3 | WKN A2QJCT. The current Eurofins Scientific stock price is 67.04 EUR (2026). Revenue is 7.76 B EUR. Net income is 755.46 M EUR. The P/E ratio is 16.59. Market capitalization is 12.54 B EUR. Eurofins Scientific operates in the Health sector.

Eurofins Scientific stock price

Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Eurofins Scientific over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Eurofins Scientific stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Eurofins Scientific's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Eurofins Scientific Stock Price History
DateEurofins Scientific Price
Access this data via the Eulerpool API
Get Free API Key

Eurofins Scientific Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2006
370.2 M EUR
38.32 M EUR
17.51 M EUR
Jan 1, 2007
491.77 M EUR
39.07 M EUR
17.64 M EUR
Jan 1, 2008
632.76 M EUR
48.1 M EUR
17.71 M EUR
Jan 1, 2009
640.07 M EUR
41.51 M EUR
-11.23 M EUR
Jan 1, 2010
680.33 M EUR
63.05 M EUR
23.4 M EUR
Jan 1, 2011
828.93 M EUR
109.45 M EUR
43.82 M EUR
Jan 1, 2012
1.04 B EUR
131.12 M EUR
53.8 M EUR
Jan 1, 2013
1.23 B EUR
161.9 M EUR
53.13 M EUR
Jan 1, 2014
1.41 B EUR
189.88 M EUR
77.98 M EUR
Jan 1, 2015
1.95 B EUR
264.33 M EUR
56.36 M EUR
Jan 1, 2016
2.54 B EUR
357.62 M EUR
138.37 M EUR
Jan 1, 2017
2.97 B EUR
399.56 M EUR
179.44 M EUR
Jan 1, 2018
3.78 B EUR
520.76 M EUR
175.32 M EUR
Jan 1, 2019
4.56 B EUR
573.5 M EUR
145.5 M EUR
Jan 1, 2020
5.44 B EUR
1.02 B EUR
505.3 M EUR

Eurofins Scientific Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jun 10, 2026, 1:59 PM
 
REVENUE (M EUR)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M EUR)
NET INCOME (M EUR)
NET INCOME GROWTH (%)
DIV. (EUR)
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Eurofins Scientific generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Eurofins Scientific retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Eurofins Scientific's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Eurofins Scientific has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Eurofins Scientific's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Eurofins Scientific stock margins

The Eurofins Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eurofins Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eurofins Scientific.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2006
60.91 %
10.35 %
4.73 %
Jan 1, 2007
60.53 %
7.94 %
3.59 %
Jan 1, 2008
60.24 %
7.6 %
2.8 %
Jan 1, 2009
60.83 %
6.49 %
-1.76 %
Jan 1, 2010
62.73 %
9.27 %
3.44 %
Jan 1, 2011
18.29 %
13.2 %
5.29 %
Jan 1, 2012
16.91 %
12.56 %
5.15 %
Jan 1, 2013
17.89 %
13.21 %
4.34 %
Jan 1, 2014
18.47 %
13.46 %
5.53 %
Jan 1, 2015
18.5 %
13.55 %
2.89 %
Jan 1, 2016
18.91 %
14.1 %
5.46 %
Jan 1, 2017
18.74 %
13.45 %
6.04 %
Jan 1, 2018
19.04 %
13.77 %
4.64 %
Jan 1, 2019
20.4 %
12.57 %
3.19 %
Jan 1, 2020
25.97 %
18.82 %
9.29 %

Eurofins Scientific Stock Revenue, EBIT, Earnings per Share

The Eurofins Scientific earnings per share therefore indicates how much revenue Eurofins Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2006
2.48 EUR
0.26 EUR
0.12 EUR
Jan 1, 2007
3.26 EUR
0.26 EUR
0.12 EUR
Jan 1, 2008
4.17 EUR
0.32 EUR
0.12 EUR
Jan 1, 2009
4.51 EUR
0.29 EUR
-0.08 EUR
Jan 1, 2010
4.58 EUR
0.42 EUR
0.16 EUR
Jan 1, 2011
5.29 EUR
0.7 EUR
0.28 EUR
Jan 1, 2012
6.6 EUR
0.83 EUR
0.34 EUR
Jan 1, 2013
7.66 EUR
1.01 EUR
0.33 EUR
Jan 1, 2014
8.78 EUR
1.18 EUR
0.49 EUR
Jan 1, 2015
11.99 EUR
1.63 EUR
0.35 EUR
Jan 1, 2016
14.96 EUR
2.11 EUR
0.82 EUR
Jan 1, 2017
16.51 EUR
2.22 EUR
1 EUR
Jan 1, 2018
20.66 EUR
2.85 EUR
0.96 EUR
Jan 1, 2019
24.53 EUR
3.08 EUR
0.78 EUR
Jan 1, 2020
27.76 EUR
5.23 EUR
2.58 EUR

Eurofins Scientific business model & stock analysis

Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide. Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing. The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics. The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs. Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint. Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing. In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases. Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples. In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals. In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses.

Eurofins Scientific SWOT Analysis

Strengths

Eurofins Scientific SE is recognized as an innovative market leader in the field of bio-analytical testing services. The company has a strong track record of developing cutting-edge technologies and solutions, providing them with a competitive advantage over their peers.

Eurofins operates a vast network of laboratories and offices across the globe, allowing them to serve a wide range of customers in various industries. This extensive global presence enables them to tap into diverse markets and leverage economies of scale.

Weaknesses

Eurofins relies on external suppliers for certain key materials and technologies. This dependence may pose challenges in terms of cost, quality control, and supply chain management. Any disruptions in the supply chain could negatively impact the company's operations.

Eurofins Scientific SE operates in a complex industry with diverse testing requirements and regulatory frameworks. Managing this level of complexity requires a high degree of expertise and resources. Any lapses in operational efficiency may result in delays and increased costs.

Opportunities

The global demand for bio-analytical testing services is expected to grow in the coming years due to factors such as increased regulatory requirements, rising consumer awareness, and advancements in technology. Eurofins can capitalize on this trend by expanding its service offerings and geographic reach.

Eurofins has the opportunity to expand its presence in emerging markets where demand for testing services is projected to experience significant growth. By establishing strategic partnerships and investing in infrastructure, the company can gain a strong foothold in these promising markets.

Threats

The bio-analytical testing services industry is highly competitive, with several global and local players vying for market share. Eurofins faces the threat of aggressive pricing strategies, technological advancements by competitors, and the potential entry of new disruptive players.

Eurofins operates in a regulatory environment that is subject to frequent changes and stringent standards. Compliance with evolving regulations and maintaining necessary accreditations can be demanding and time-consuming, potentially impacting the company's ability to deliver timely and cost-effective services.

Eurofins Scientific Eulerpool Fair Value

Eurofins Scientific historical P/E ratio, EBIT multiple, and P/S ratio

Eurofins Scientific annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Eurofins Scientific shares outstanding

The number of shares was Eurofins Scientific in 2025 — This indicates how many shares 187 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2006
149.39 M base_Shares
Jan 1, 2007
150.77 M base_Shares
Jan 1, 2008
151.78 M base_Shares
Jan 1, 2009
141.83 M base_Shares
Jan 1, 2010
148.59 M base_Shares
Jan 1, 2011
156.84 M base_Shares
Jan 1, 2012
158.06 M base_Shares
Jan 1, 2013
159.94 M base_Shares
Jan 1, 2014
160.6 M base_Shares
Jan 1, 2015
162.66 M base_Shares
Jan 1, 2016
169.57 M base_Shares
Jan 1, 2017
179.98 M base_Shares
Jan 1, 2018
183.01 M base_Shares
Jan 1, 2019
186 M base_Shares
Jan 1, 2020
195.9 M base_Shares

Eurofins Scientific Dividend History

18 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.6EUR↑ 20.0%1×
Apr 28, 20250.6EUR↑ 20.0%1/1
20240.5EUR↓ 50.0%1×
20231EUR 0.0%1×
20221EUR↑ 47.1%1×
20210.68EUR↓ 76.4%1×
20192.88EUR↑ 20.0%1×
20182.4EUR↑ 20.0%1×
20172EUR↑ 37.9%1×
20161.45EUR↑ 9.8%1×
20151.32EUR↑ 10.0%1×

Eurofins Scientific dividend history and estimates

In 2025, Eurofins Scientific paid a dividend amounting to 0.6 EUR. Dividend means that Eurofins Scientific distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2007
0.1 EUR
0 EUR
Jan 1, 2008
0.1 EUR
0 EUR
Jan 1, 2009
0.1 EUR
0 EUR
Jan 1, 2010
0.1 EUR
0 EUR
Jan 1, 2011
0.2 EUR
0 EUR
Jan 1, 2012
0.8 EUR
0 EUR
Jan 1, 2013
1 EUR
0 EUR
Jan 1, 2014
1.2 EUR
0 EUR
Jan 1, 2015
1.32 EUR
0 EUR
Jan 1, 2016
1.45 EUR
0 EUR
Jan 1, 2017
2 EUR
0 EUR
Jan 1, 2018
2.4 EUR
0 EUR
Jan 1, 2019
2.88 EUR
0 EUR
Jan 1, 2021
0.68 EUR
0 EUR
Jan 1, 2022
1 EUR
0 EUR

Eurofins Scientific dividend payout ratio

In 2025, Eurofins Scientific had a payout ratio of 29.51%. The payout ratio indicates the percentage of the company's profits that Eurofins Scientific distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2006
29.84 %
Jan 1, 2007
8.33 %
Jan 1, 2008
8.33 %
Jan 1, 2009
-12.5 %
Jan 1, 2010
6.25 %
Jan 1, 2011
7.41 %
Jan 1, 2012
23.53 %
Jan 1, 2013
30.3 %
Jan 1, 2014
25 %
Jan 1, 2015
38.82 %
Jan 1, 2016
17.9 %
Jan 1, 2017
20.2 %
Jan 1, 2018
25.26 %
Jan 1, 2019
36.92 %
Jan 1, 2020
29.84 %
Price targets and forecasts for Eurofins Scientific are not yet available.

Eurofins Scientific Earnings Estimates

Eurofins Scientific Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
11/7/20110.11EUR216.19 MEUR2011 Q3
11/8/20100.07EUR176.61 MEUR2010 Q3
3/3/2010-EUR174.58 MEUR2009 Q4
11/12/2009-EUR165.44 MEUR2009 Q3
8/31/2009-EUR164.43 MEUR2009 Q2
5/14/2009-EUR153.82 MEUR2009 Q1
3/5/2009-EUR180.97 MEUR2008 Q4
11/13/2008-EUR152.35 MEUR2008 Q3
8/29/2008-EUR152.76 MEUR2008 Q2
3/5/20080.07EUR160.17 MEUR2007 Q4

EESG©

Eulerpool ESG Scorecard© for the Eurofins Scientific stock

90/100
99
Environment
99
Social
71
Governance
E

Environment

20
Scope 1 - Direct Emissions61,790
Scope 2 - Indirect emissions from purchased energy149,493
Scope 3 - Indirect emissions within the value chain290,440
Total CO₂ emissions211,283
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees57
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Eurofins Scientific shareholder structure

% Name
33.97037%
Gilles Martin Family
Gilles Martin Family
2.40475%
Harris Associates L.P.
Harris Associates L.P.
1.95349%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.83983%
1832 Asset Management L.P.
1832 Asset Management L.P.
1.56474%
Ruane, Cunniff & Goldfarb L.P.
Ruane, Cunniff & Goldfarb L.P.
1.53498%
Norges Bank Investment Management (NBIM)
Norges Bank Investment Management (NBIM)
1.44861%
Capital Research Global Investors
Capital Research Global Investors
1.32946%
RBC Global Asset Management (UK) Limited
RBC Global Asset Management (UK) Limited
1.25914%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
1.12918%
Swedbank Robur Fonder AB
Swedbank Robur Fonder AB
...

Eurofins Scientific Executives and Management Board

GM

Dr. Gilles Martin

(62)

Chairman of the Board, Chief Executive Officer

Compensation5.16 M EUR
VH

Mrs. Valerie Hanote

(59)

Executive Director

Compensation435,000 EUR
PR

Mr. Pascal Rakovsky

(64)

Lead Non-Executive Independent Director

Compensation96,300 EUR
PL

Mrs. Patrizia Luchetta

(61)

Non-Executive Independent Director

Compensation71,067 EUR
ER

Ms. Evie Roos

(58)

Non-Executive Independent Director

Compensation67,300 EUR

Frequently asked questions about Eurofins Scientific

The business model of Eurofins Scientific SE revolves around providing a comprehensive range of laboratory testing services to various industries worldwide. Eurofins Scientific SE offers a wide array of services, including testing and analysis of food, environment, pharmaceuticals, cosmetics, and other materials. With a vast network of laboratories and expertise in different domains, Eurofins Scientific SE caters to the specific needs of its clients, ensuring the highest quality standards are met. By leveraging advanced technology and a strong commitment to innovation, Eurofins Scientific SE positions itself as a leading player in the global testing and scientific services industry, delivering reliable and efficient solutions to its customers.

All fundamentals and in-depth analysis of Eurofins Scientific

Our stock analysis for Eurofins Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurofins Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Eurofins Scientific Stock
Eurofins Scientific Revenue→
Eurofins Scientific Stock
Eurofins Scientific Net Income→
Eurofins Scientific Stock
Eurofins Scientific P/E→
Eurofins Scientific Stock
Eurofins Scientific P/S→
Eurofins Scientific Stock
Eurofins Scientific EBIT→
Eurofins Scientific Stock
Eurofins Scientific Dividend→
Eurofins Scientific Stock
Eurofins Scientific Directors Dealings→
Eurofins Scientific Stock
Eurofins Scientific Stocks→
Eurofins Scientific Stock
Eurofins Scientific Market capitalization→
Eurofins Scientific Stock
Eurofins Scientific Debt→
Eurofins Scientific Stock
Eurofins Scientific Liabilities→
Eurofins Scientific Stock
Eurofins Scientific Equity→
Eurofins Scientific Stock
Eurofins Scientific AAQS→
Eurofins Scientific Stock
Eurofins Scientific Employees→
Eurofins Scientific Stock
Eurofins Scientific ROE→
Eurofins Scientific Stock
Eurofins Scientific ROA→
Eurofins Scientific Stock
Eurofins Scientific ROCE→